Recruiting
Phase 2

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Sponsor:

Children's Oncology Group

Code:

NCT05504291

Conditions

Bilateral Retinoblastoma

Childhood Intraocular Retinoblastoma

Group D Retinoblastoma

Stage I Retinoblastoma

Unilateral Retinoblastoma

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-03-25.